1. Home
  2. ODTX vs PGY Comparison

ODTX vs PGY Comparison

Compare ODTX & PGY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Odyssey Therapeutics Inc. Common Stock

ODTX

Odyssey Therapeutics Inc. Common Stock

N/A

Current Price

$16.85

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Logo Pagaya Technologies Ltd.

PGY

Pagaya Technologies Ltd.

N/A

Current Price

$13.52

Market Cap

1.1B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
ODTX
PGY
Founded
2021
2016
Country
United States
United States
Employees
N/A
503
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
2025
2021

Fundamental Metrics

Financial Performance
Metric
ODTX
PGY
Price
$16.85
$13.52
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
11
Target Price
★ $34.67
$29.45
AVG Volume (30 Days)
291.0K
★ 1.8M
Earning Date
11-04-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 116.43
EPS
N/A
★ 1.30
Revenue
N/A
★ $1,301,360,000.00
Revenue This Year
N/A
$12.99
Revenue Next Year
N/A
$16.38
P/E Ratio
★ N/A
$11.25
Revenue Growth
N/A
★ 26.07
52 Week Low
$15.10
$10.40
52 Week High
$29.05
$26.80

Technical Indicators

Market Signals
Indicator
ODTX
PGY
Relative Strength Index (RSI) 36.09 27.93
Support Level $15.73 $12.46
Resistance Level $19.60 $16.42
Average True Range (ATR) 1.69 1.01
MACD -0.19 -0.41
Stochastic Oscillator 6.10 1.67

Price Performance

Historical Comparison
ODTX
PGY

About ODTX Odyssey Therapeutics Inc. Common Stock

Odyssey Therapeutics Inc is a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases. The Company is developing medicines that are designed to precisely target disease pathology with an initial emphasis on the innate immune system. Its programs include OD-07656, a small molecule scaffolding inhibitor of receptor-interacting protein kinase 2, or RIPK2, a small molecule scaffolding inhibitor of interleukin-1 receptor-associated kinase 4, or IRAK4, and OD-00910, an agonistic protein therapeutic targeting tumor necrosis factor receptor 2, or TNFR2, built from camelid heavy chain variable regions, or VHH, domains.

About PGY Pagaya Technologies Ltd.

Pagaya Technologies Ltd is a product-focused technology company. It uses machine learning, a vast data network, and an AI-driven approach to offer comprehensive consumer credit and residential real estate products for its partners, their customers, and investors. Its suite of products includes Decline Monetization, Dual Look, First Look, Affiliate Optimizer Engine, Direct Marketing Engine, and FastPass, providing lenders with an AI-powered credit and acquisition ecosystem that helps them approve more borrowers, capture more demand, and grow without adding risk. Geographically, the company generates maximum revenue from its business in the United States.

Share on Social Networks: